The Aptima® SARS-CoV-2 assay is a nucleic acid amplification in vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria.
Save this product for later
Sign up to receive public health supply chain news from PFSCM
